Sun Pharma receives 11 observations from US FDA for Dadra plant
The news has caused Sun Pharma’s stock to fall as much as three per cent
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Cliantha Research acquires Inflamax Research
With the new acquisition, Cliantha Research will have the capabilities to perform Phase I, II, III and IV clinical research in…
Avantor acquires Puritan products
Acquisition bolsters Avantor’s portfolio of high-purity cGMP materials and solutions for Biopharma, Research, and Electronic…
Aurobindo Pharma gets six observations from US FDA for Hyderabad unit
US FDA had conducted an inspection at the company’s Unit III, a formulations manufacturing facility at Bachupally, Hyderabad
Piramal Enterprises partners with IPA
Piramal Enterprises and IPA jointly will organise Chemist Awareness Programmes in different locations across India and chemists…
Clarivate Analytics unveils ‘India Innovation: Trends’ report
Pharma contributed 15 per cent of the total patents published in the top 10 DWPI categories in India
Plant protein may protect against type II diabetes, meat eaters at greater risk: Study
Source of dietary protein may play a role in the risk of developing type-II diabetes
Rusan Pharma launches anti-tobacco/ smoking awareness campaign
2baconil associates with Kings XI Punjab as health partner
Glenmark gets tentative US FDA nod for anti-coagulant drug
The product is the generic version of Pradaxa capsules, 75 mg, 110 mg and 150 mg of Boehringer Ingelheim Pharmaceuticals
Alembic Pharma gets tentative US FDA nod for anti-depressant tabs
According to IMS, the tablets have an estimated market size of $340 million for 12 months to December 2016
Mergermarket releases global PMB trend report
Biotech was the largest subsector by value with 42 deals worth $38.8 billion
Orchid Pharma receives EIR from US FDA for Tamil Nadu plant
The report was issued based on the successful inspection of the formulation manufacturing facility at Irungattukottai
Jubilant Life raises Rs 100 cr by issue of commercial papers
The tenure of instrument is 63 days, Jubilant Life Sciences said in a BSE filing
8th Annual Clinical Trials Summit 2017 to be held in Mumbai
The 2017 programme will focus on key issues and opportunities in the clinical trial industry, including patient recruitment, site…
US FDA inspects Alembic Pharma’s Vadodara plant
At the end of the observation, no Form 483s were issued
Unichem Laboratories receives ANDA approval from US FDA for piroxicam caps
Piroxicam is a non-steroidal anti-inflammatory drug indicated for relief of the signs and symptoms of osteoarthritis and…
Technology is key to improve R&D efficacy and cost effectiveness: Morgan Stanley report
It also highlights global tech companies’ investments to leverage opportunities arising through healthcare and technology…
BCPL posts net profit of Rs 4 crore
The company made a turnaround in 2016-17 after a gap of 40 years
MoH&FW, DCG(I) grants approval to RMS Regrow for Chondron
Chondron ACI is indicated for the treatment of cartilage defects of the joints
RMS Regrow bags approval from MoH&FW and DCG(I)
Chondron ACI is indicated for the treatment of cartilage defects of the joints